ADMA Biologics Inc (ADMA)

[OwnThePlayOTC]

Hard to believe that people aren’t scooping up shares as fast as possible. Hopefully Trump mentions it tonight and we gap up tomorrow

$ADMA $SONN

[PetroTech]

Is that it? Is ADMA a dud or is it going to take off soon?

[OwnThePlayOTC]

Strong close!

$ADMA

[OwnThePlayOTC]

Looking good pre-market!

$ADMA

[value1008]

I actually like Clay's brief charting on trending stocks, but most unfortunately he seems to be followed by a bunch of high-pressure shortsellers (and naked shortsellers) who usually seem to destroy a lot of shareholder value in their wake.

[ttubular]

Go away

[ClayTrader]

* * $ADMA Video Chart 08-24-2020 * *

Link to Video - click here to watch the technical chart video

[ttubular]

It would be nice for Adma to come out with a pr. Let us now how everything is going to work and projections

[OwnThePlayOTC]

Looking strong!

[MMoney007]

Hopefully it goes over 4 in AH

[OwnThePlayOTC]

Time to push again. let’s go!!!

$ADMA

[OwnThePlayOTC]

It’s coming!

[MMoney007]

Seems like it’s ready to take off

[OwnThePlayOTC]

BOOM!

[OwnThePlayOTC]

Lol. Seems to be the case.

$ADMA

[noreen]

Because they don’t want you to make money.

[Bangara100]

$2.88 support massive accumulation...expecting a very big spike over the next few days...

[OwnThePlayOTC]

About to go again

$ADMA

[Bangara100]

Any reason why ADMA is not spiking on such a good news...too many shorts ????

[$treet $inatra]

ADMA filling the gap from the premarket craziness nice upward push thanks to Trump:

https://www.fool.com/investing/2020/08/24/why-adma-biologics-ibio-and-kamada-are-jumping-tod/

https://www.barrons.com/articles/plasma-stocks-fda-covid-19-treatment-mayo-clinic-randomized-study-white-house-51598277140?siteid=yhoof2

[OwnThePlayOTC]

Added here 2.95

$ADMN

[Street Smart]

looks good

[mick]

$ADMA Revenue and Earnings Estimates (source: Seeking Alpha)

As you can see from Figure 5, ADMA’s P/S ratio drops to under a 3 for
every year after this one,
and ADMA’s P/E ratio off of future earnings estimates is well below the average of 15 for virtually every year after ADMA is projected to achieve profitability.


Even if you discounted these sales and earnings estimates by 10% per year as shown in Figure 6, these ratios would still suggest that ADMA is meaningfully undervalued.

Based on this valuation and commercial progress,
ADMA seems fairly de-risked under $3/share, but ADMA is also de-risked based on the fundamentals of plasma-based therapies in general.

IG is a great market to be in right now.

https://seekingalpha.com/article/4370328-adma-biologics-is-bargain-again-after-recent-sell-off

[mick]

$ADMA [-chart]static.seekingalpha.com/uploads/2020/8/23/4562691-15982152370618997.png[/chart]



https://seekingalpha.com/article/4370328-adma-biologics-is-bargain-again-after-recent-sell-off

Figure 4: ADMA Financial Highlights (source: ADMA’s August 2020 Corporate Presentation)

ADMA’s current burn rate of about $80 million per year suggests that the company will need at least one more raise by early next year,
but after that product sales will hopefully have grown to a level where they can sustain the business without further dilution.

Analyst estimates back this up, suggesting the company will show positive cash-flow in 2022.

ADMA’s long-term debt level is significant at just under $100 million
in total, and it’s worth noting that all of it appears to mature in 2022.

ADMA will likely have positive cash-flow by then, but not enough of it to pay off that much debt. Something to watch for will be whether ADMA can find a non-dilutive way to raise some additional cash or restructure its debt by then.

An obvious risk for the company though is that if sales disappoint or costs of the infrastructure build-out overrun substantially,
ADMA could have to rely on further dilutive cash raises to keep its business afloat and pay down its debt.

Such a move could result in big losses for current shareholders.

ADMA is only trading at about 5x current sales, but analysts agree with the company that ADMA is in for substantial revenue growth over the next few years.

[mick]

$ADMA ADMA Is Still Very Undervalued Based On The Company’s Current Trajectory And The Broader Market Outlook For Plasma-Based Products
ADMA is well-positioned now to capitalize on its growing product sales
and plasma collection infrastructure. ADMA sales are growing rapidly as discussed above, and ADMA also has a good amount of cash on hand after raising $88.7 million in Q1.

https://seekingalpha.com/article/4370328-adma-biologics-is-bargain-again-after-recent-sell-off

[mick]

$ADMA Now on the evening of August 23, the FDA issued an Emergency Use Authorization for convalescent plasma in treating COVID-19 despite the
more cautionary tone heard the week prior.

https://marketwirenews.com/news-releases/3-penny-stocks-to-watch-after-trump-s-emergency-plas-6087954188974667.html?i=ib


In my view, the COVID-19 indication is basically a free call option for
a long-term ADMA investor.

The potential use of ADMA plasma in battling COVID-19 is not factored
into any of what I discussed above regarding ADMA’s strong progress
towards being a highly profitable business,
and as will be discussed more below,
IG demand is huge and growing without factoring in any potential demand from the pandemic.

[mick]

$ADMA good morning early risers

[djmurdock]

Read the link I just posted, lot's of info.

[djmurdock]

https://seekingalpha.com/article/4370328-adma-biologics-is-bargain-again-after-recent-sell-off

[Bangara100]

But how does and how much does it help ADMA and what other companies are competing against ADMA?

[0whammies]

luv it

[ttubular]

I guess we will be burning clay n his followers

[0whammies]

Clay was here recently....video chart.....got shorted heavily after.

[djmurdock]

No problem, best of luck!

[OM33025]

Thank you for the reply. I did not see the news conference. I hope it blasts and everyone, except one rude person, makes a mint! Kodak style!

[djmurdock]

Huge news, Trump just announced breakthrough therapeutics with blood plasma, granting EUA to companies like ADMA.

Big pop coming this week!

[OM33025]

Why is this a boom?

[420man]

ASAP! BOOM!

[adtime]

OH MY

[stockmule]

Any reason why this has broken down below 3.00 Management was buying at 3 and over so considering a buy here at 2.85 or lower

[RealPainkiller]

We're starting to move here. Today is the CC at 3:30 central time..4:30 eastern

[ClayTrader]

* * $ADMA Video Chart 07-31-2020 * *

Link to Video - click here to watch the technical chart video

[RealPainkiller]

We have some wall here at 3.55..Monday we should be back to business and keep moving up

[RealPainkiller]

$ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020

https://www.globenewswire.com/news-release/2020/07/29/2069288/0/en/ADMA-Biologics-to-Report-Business-Highlights-and-Second-Quarter-2020-Financial-Results-on-August-5-2020.html#.XyPmzR6PyeM.twitter

[ClayTrader]

* * $ADMA Video Chart 07-30-2020 * *

Link to Video - click here to watch the technical chart video

[RealPainkiller]

Thanks. You too. Looks good so far.

[now invest]

Thanks for posting... was looking for after market action!! Good luck here....

[CrazyKar123]

gap will fill and some will chase

[RealPainkiller]

Brian
@investor6969
$ADMA ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients.

https://benzinga.com/z/16846115#.XyKuO18Z5xs.twitter via
@benzinga

[now invest]

Wow !!! Big move after hours!! Around 35%!!!